Publications
2 shownChemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial
Purpose Docetaxel added to androgen-deprivation therapy (ADT) significantly increases the longevity of some patients with metastatic hormone-sensitive prostate cancer. Herein, w...
Frequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 2
- Citations
- 1,049
- Institution
- Dana-Farber Cancer Institute
External Links
Identifiers
- ORCID
- 0000-0003-4292-698X
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.